Acme Progen Biotech (India) Private Limited, a active private limited company, was established on 10 July 2007 in Salem, Tamil Nadu, India. Engaging in research & development within the professional, scientific and technical sector, it holds CIN: U33111TZ2007PTC013847. Registered under ROC Roc Coimbatore. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
It upholds a compliant status. Its leadership includes Venkatesan Ganesan (Director), Appuchigounder Rathanam (Director), Mani Chitra (Director). Past directors included Venkatesan Ganesan, Mani Suganthi, Appuchigounder Rathanam. It holds no open charges and ₹1.90 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Rams Square 260 G Balaji Nagar Advaitha Ashram Road, Salem, Tamil Nadu, 636004.
U33111TZ2007PTC013847
013847
10 July 2007
₹1.00 M
₹1.00 M
Roc Coimbatore
Unlisted
Active
Explore comprehensive insights into Acme Progen Biotech (India) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Venkatesan Ganesan | Director | 30 Nov 2021 | Current |
| Appuchigounder Rathanam | Director | 04 Apr 2018 | Current |
| Mani Chitra | Director | 10 Jul 2007 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Managing Director | 05 Oct 2015 | Past |
| Pramod Abcsdd | Additional Director | 20 Mar 2013 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Acme Progen Biotech (India) Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 19.54% decrease. The company also saw a slight decrease in profitability, with a 7.73% decrease in profit. The company's net worth moved up by a moderate rise of 9.01%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2017, Acme Progen Biotech (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹1,900,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Jun 2018 | Indian Bank | ₹1.00 M | Satisfied |
| 05 Dec 2007 | The Lakshmi Vilas Bank Ltd | ₹0.90 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Acme Progen Biotech (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Acme Progen Biotech (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Acme Progen Biotech (India)'s trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge registered on 27 Jun 2018 via Charge ID 100212631 with Indian Bank was fully satisfied on 05 Oct 2024. was recorded as a recent event.
The activity Acme Progen Biotech (India) Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Acme Progen Biotech (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Coimbatore. was recorded as a recent event.
The activity Venkatesan Ganesan was appointed as a Director was appointed as a Director on 30 Nov 2021 & has been associated with this company since 3 years 11 months . was completed.
The activity A charge with Indian Bank of Rs. 1.00 M registered on 27 Jun 2018 with Charge ID 100212631 was modified on 06 Jul 2019. was completed.
The activity A charge with Indian Bank amounted to Rs. 1.00 M with Charge ID 100212631 was registered on 27 Jun 2018. was completed.
The CIN of Acme Progen Biotech (India) Private Limited is U33111TZ2007PTC013847.
Acme Progen Biotech (India) Private Limited is headquartered at Rams Square 260 G Balaji Nagar Advaitha Ashram Road, Salem, Tamil Nadu, 636004.
Acme Progen Biotech (India) Private Limited was incorporated on 10 July 2007.
The current directors of Acme Progen Biotech (India) Private Limited are
The primary industry of Acme Progen Biotech (India) Private Limited is Professional, Scientific And Technical.
Acme Progen Biotech (India) Private Limited is unlisted.
The authorized capital of Acme Progen Biotech (India) Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
The compliance status of Acme Progen Biotech (India) Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX